CEACAM5 and colonic neoplasm: Our previous study in immunocompetent CEA transgenic (CEA-Tg) mice that express the same antigen as human in endogenous organs demonstrated specific CAR-T cell responses in CEA positive breast and colon tumor models without any observed off-target effects (22).